Trans-Tranilast
Product Specifications
CAS Number
70806-55-2
Target
RAAS
Related Pathways
Endocrinology/Hormones
Purity
0.9996
Bioactivity
Trans-Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. It was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
Smiles
N(C(/C=C/C1=CC(OC)=C(OC)C=C1)=O)C2=C(C(O)=O)C=CC=C2
Molecular Formula
C18H17NO5
Molecular Weight
327.33
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0034319-01 20 µL
Monoclonal Antibody to Complement component 1 Q subcomponent-binding protein, mitochondrial (C1QBP)
Sign In for Pricing
View Details TRV-0034319-02 100 µL
Monoclonal Antibody to Complement component 1 Q subcomponent-binding protein, mitochondrial (C1QBP)
Sign In for Pricing
View Details TRV-0034319-03 200 µL
Monoclonal Antibody to Complement component 1 Q subcomponent-binding protein, mitochondrial (C1QBP)
Sign In for Pricing
View Details TRV-0034319-04 1 mL
Monoclonal Antibody to Complement component 1 Q subcomponent-binding protein, mitochondrial (C1QBP)
Sign In for Pricing
View Details 
K6045402 1.0 µg DNA
Luc7l2 sgRNA CRISPR Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details 